Barclays now sees two Fed cuts this year, says jumbo Fed cuts ’very unlikely’
In a recent transaction, Janet Jill Hopkins, the Chief Medical (TASE:PMCN) Officer at Aura Biosciences , Inc. (NASDAQ:AURA), a $397 million market cap biotechnology company, sold 2,534 shares of common stock. While the company maintains strong liquidity with a current ratio of 12.47, InvestingPro analysis shows it’s currently burning through cash rapidly. The shares were sold at a price of $7.75 each, resulting in a total transaction value of $19,638. Following the sale, Hopkins retains ownership of 269,794 shares in the company.
According to the filing, these sales were automatically executed to cover tax withholding obligations tied to the vesting of restricted stock units and were not made at Hopkins’ discretion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.